NYSE:ZBHMedical Equipment
A Look At Zimmer Biomet (ZBH) Valuation After Revenue Beat EPS Miss And Acquisition Progress
Zimmer Biomet Holdings (ZBH) drew fresh attention after reporting 10.9% year-on-year revenue growth that came in 0.9% above analyst expectations, while slightly missing full-year EPS guidance despite progress on EPS, free cash flow, and acquisitions.
See our latest analysis for Zimmer Biomet Holdings.
The latest earnings update landed against a weak share price backdrop, with a 30 day share price return showing an 11% decline and a 1 year total shareholder return showing a 19.86% decline...